Centrum recommended hold rating on Dr Reddy's Lab with a target price of Rs 2970 in its research report dated February 06, 2017.
ICICI Direct recommended hold rating on Dr Reddy‘s Laboratories with a target price of Rs 2930 in its research report dated February 07, 2017.
KR Choksey has recommended accumulate rating on Dr. Reddy‘s Laboratories with a target price of Rs 3523 in its research report dated February 06, 2017.
In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, Prakash Diwan of Altamount Capital Management shared his reading and outlook on the market and also gave recommendations on various stocks.
With Nifty a whisker away from its lifetime high and valuation touching 21X FY17P and 18X FY18P earnings, the Street looks cautious. Is it time to take money off the table?
Dolat Capital is bullish on Dr. Reddy's Laboratories has recommended buy rating on the stock with a target price of Rs 4200 in its research report dated October 26, 2016.
Centrum recommended hold rating on Dr. Reddy‘s Labs with a target price of Rs 3370 in its research report dated October 26, 2016.
Edelweiss recommended hold rating on Dr. Reddys Laboratories with a target price of Rs 2720 in its research report dated October 25, 2016.
KR Choksey has recommended accumulate rating on Dr. Reddy‘s Laboratories with a target price of Rs 3523 in its research report dated October 26, 2016.
KRChoksey is bullish on Dr. Reddy‘s Laboratories has recommended accumulate rating on the stock with a target price of Rs 3,366 in its research report dated July 27, 2016.
Axis Direct is bearish on Dr Reddy's has recommended sell rating on the stock with a target price of Rs 2650, in its research report dated July 27, 2016.
Religare is bearish on Dr Reddys has recommended sell rating on the stock with a target price of Rs 2800 in its research report dated July 27, 2016.
Religare recommended hold rating on Dr. Reddys with a target price of Rs 3280 in its research report dated June 27, 2016.
Religare has recommended hold rating on Dr Reddys Labs with a target of Rs 3280 in its research report June 13, 2016.
Edelweiss has recommended hold rating on Dr Reddys Labs with a target price of Rs 3120 in its research report dated February 10, 2016.
Prabhudas Lilladher is bullish on Dr Reddys Labs has recommended buy rating on the stock with a target price of Rs 3083 in its research report dated Februrary 10, 2016.
KRChoksey is bullish on Dr Reddys Labs has recommended buy rating on the stock with a target price of Rs 3610 in its research report dated Februrary 10, 2016.
Motilal Oswal has recommended neutral rating on Dr Reddys Labs with a target price of Rs 3500 in its research report dated November 26, 2015.
Sharekhan has come out with its report on top stocks picks. Ashok Leyland, Bajaj Finance, Britannia Industries, Cadila Healthcare, Dr. Reddy‘s Lab, IndusInd Bank, Maruti Suzuki Relaxo Footwear, Reliance Industries, SBI, TCS and Zee Entertainment are amongst the list.
Emkay has recommended hold rating on DrReddys Labs with a target price of Rs 4224 in its research report dated October 29, 2015.
KRChoksey is bullish on Dr Reddys Laboratories and has recommended Accumulate rating on the stock with a target price of Rs 4793 in its research report dated October 30, 2015
Watch the interview of technical analyst, SP Tulsian of sptulsian.com with Latha Venkatesh and Sonia Shenoy of CNBC-TV18. He shared his reading and outlook on the market and also gave recommendations on various stocks.
ICICIdirect.com has advised to buy Dr Reddys Laboratories in the range of Rs 4140-4190 for a target price of Rs 4770 with a stop loss below Rs 3870 on a closing basis, in its research report dated September 30, 2015.
ICICIdirect.com has come out with its top picks report for July 2015. The research firm expects Sensex earnings to grow at ~18.3% each in FY16E and FY17E to Rs 1608 and Rs 1901, respectively. Hence, we assign a P/E multiple of 16.5x on FY17E EPS to arrive at a fair value of 31400 by end CY15 with the Nifty reaching 9400, says the report.
Brokerage house Prabhudas Lilladher is bullish on Dr Reddys Laboratories and has recommended 'Accumulate' rating on the stock with a target price of Rs 3878, in its research report dated May 12, 2015.